SCHEMBL6696040

SCHEMBL6696040

COc1ccc(OC(CCCl)c2ccccc2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.49
SLC6A2 P23975 4/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
CYP2D6 P10635 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
SLC6A3 Q01959 1/20 0.49
PMP22 Q01453 1/20 0.48
HTR1A P08908 2/20 0.46
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659467 1.00 SLC6A4 (0.49) SLC6A4SLC6A2MEN1KMT2ACYP2D6
SCHEMBL5405164 0.86 SLC6A2 (0.55) SLC6A4SLC6A2MEN1KMT2ACYP2D6
SCHEMBL5078074 0.83 SLC6A4 (0.59) SLC6A4
SCHEMBL6725319 0.83 SLC6A2 (0.68) SLC6A4SLC6A2MEN1KMT2ACYP2D6
SCHEMBL9772801 0.83 SLC6A2 (0.68) SLC6A4SLC6A2MEN1KMT2ACYP2D6
SCHEMBL14169727 0.81 SLC6A2 (0.48) SLC6A4SLC6A2MEN1KMT2ACYP2D6
SCHEMBL6006366 0.79 SLC6A4 (0.49) SLC6A4SLC6A2SLC6A3
SCHEMBL17835845 0.78 MAPT (0.49) SLC6A4SLC6A2MEN1KMT2ACYP2D6
SCHEMBL17835846 0.78 MAPT (0.49) SLC6A4SLC6A2MEN1KMT2ACYP2D6
SCHEMBL8202643 0.78 SLC6A4 (0.61) SLC6A4SLC6A2MEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004064774-A2 DNA ENCODING A HUMAN MELANIN CONCENTRATING HORMONE RECEPTOR (MCH1) AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2004-08-05 WO disclosed